Shaji Kumar, MD

Dr. Kumar is a Consultant in the Division of Hematology, Department of Internal Medicine at Mayo Clinic.

Articles by Shaji Kumar, MD

Saad Z. Usmani, MD, MBA, FACPMyeloma | November 14, 2022

Drs. Saad Usumani and Sydney Lu discuss adjusting multiple myeloma treatments to the realities of the COVID-19 pandemic.

Shaji Kumar, MDMyeloma | November 14, 2022

Shaji Kumar, MD, discusses B-cell maturation antigen as a target for myeloma and belantamab mafodotin.

Shaji Kumar, MDMyeloma | December 2, 2020

The ENDURANCE trial assessed carfilzomib versus bortezomib plus lenalidomide and dexamethasone for newly diagnosed MM.

Shaji Kumar, MDMyeloma | November 14, 2022

Shaji Kumar, MD, highlighted how the treatment paradigm may change in the coming years.